Findings

What do systematic reviews say?

4 questions · 6 findings · 1 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 6 · 100%High 0 · 0%

3‐year OS · patients with epithelial ovarian cancer

Platin‐based maintenance chemotherapy showed no clear difference in 3‐year OS compared with observation (moderate certainty).

1 finding from 1 review

Maintenance chemotherapy for ovarian cancer 2013 · Cochrane Headline outcomes only
RR 1.06 [0.94, 1.18]
3 studies · 341 participants
Moderate

5‐year OS · patients with epithelial ovarian cancer

Platin‐based maintenance chemotherapy showed no clear difference in 5‐year OS compared with observation (moderate certainty).

1 finding from 1 review

Maintenance chemotherapy for ovarian cancer 2013 · Cochrane Headline outcomes only
RR 1.07 [0.88, 1.31]
2 studies · 219 participants
Moderate

10‐year OS · patients with epithelial ovarian cancer

Platin‐based maintenance chemotherapy showed no clear difference in 10‐year OS compared with observation (moderate certainty).

1 finding from 1 review

Maintenance chemotherapy for ovarian cancer 2013 · Cochrane Headline outcomes only
RR 1.08 [0.78, 1.49]
2 studies · 219 participants
Moderate

Progression‐free survival · patients with epithelial ovarian cancer

Platin‐based maintenance chemotherapy showed no clear difference in 3‐year PFS compared with observation (moderate certainty).

3 findings from 1 review

Maintenance chemotherapy for ovarian cancer 2013 · Cochrane Headline outcomes only
RR 1.04 [0.86, 1.24]
3 studies · 341 participants
Moderate
Maintenance chemotherapy for ovarian cancer 2013 · Cochrane Headline outcomes only
RR 1.18 [0.88, 1.58]
2 studies · 219 participants
Moderate
Maintenance chemotherapy for ovarian cancer 2013 · Cochrane Headline outcomes only
RR 0.96 [0.65, 1.41]
2 studies · 219 participants
Moderate